UnknownNot Applicable

The Health-Related Quality of Life of the Patients With Symptomatic Convergence Insufficiency

China300 participantsStarted 2022-06-01

Plain-language summary

This trial is an observational cohort study. Patients aged 8-15 years with symptomatic convergence insufficiency and 150 patients with symptomatic convergence insufficiency who had not received visual training were selected from the Tianjin Eye Hospital Optometry Center and received 1 course of visual training treatment. Self-assessment and other assessments were combined, and the patient and guardian questionnaires were collected. The EQ-5D-Y and CHU9D scales were used to evaluate Chinese patients' health-related quality of life with symptomatic convergence insufficiency. The feasibility of the EQ-5D-Y and CHU9D scales in assessing the health-related quality of life of Chinese patients with symptomatic convergence insufficiency was analyzed. To assess the effectiveness of visual training on visual symptoms and improvement of quality of life in patients with symptomatic convergence insufficiency

Who can participate

Age range

8 Years – 15 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 8\~15 years old * Monocular best corrected visual acuity at distance and near was more than 0.8 * Near exophoria 4Δ greater than distance exophoria * NPC ≥ 6cm * PFV ≤15△BO * Stereogram ≤500 '' * Score of CISS questionnaire ≥16 or COVD questionnaire≥20 Exclusion Criteria: * present constant strabismus, nystagmus or vertical phoria at distance or near. * developmental delay or ocular surgery * Myopia≤ -6.00D, Hyperopia ≥ +5.00D, Astigmatism ≥ 4.00D * Monocular Amplitude of accommodation\<5D * Other diseases except myopia

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Changes in EuroQol five dimensions questionnaire(EQ-5D-5L) score

Timeframe: The changes between baseline and 3 months

Changes in shortForm 6D(SF-6D) questionnaire score

Timeframe: The changes between baseline and 3 months

Trial details

NCT IDNCT05948046

SponsorTianjin Eye Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-01

Contact for this trial

Yue Zhang, MD

+862227306525 zhangyue_1225@126.com

View on ClinicalTrials.gov More Myopia trials